Literature DB >> 1819215

Irreversible renal failure associated with triamterene.

L F Roy1, J P Villeneuve, A Dumont, L R Dufresne, M A Duran, C Morin, J Jobin.   

Abstract

A 66-year-old man was admitted with acute oliguric renal failure. The patient was known to have chronic heart failure (ejection fraction 13%) and his medication included furosemide, digoxin and triamterene. Physical examination was unremarkable, and blood pressure was 170/80 mm Hg. Serum creatinine was 1,173 mumol/l. Renal ultrasound, CT scan and angiogram were normal. Despite correction of potential reversible factors and discontinuation of triamterene, renal function did not improve. Renal biopsy showed tubular obstruction with deposition of birefringent crystals and interstitial lymphocytic infiltration; the crystals emitted a blue autofluorescence at 425 nm, typical of triamterene. Renal tissue contained large amounts of triamterene (6.44 mg/g kidney at the initial biopsy and 400 micrograms/g kidney 5 months later). Triamterene has been previously reported to cause acute reversible renal failure, but to our knowledge, this is the first case of irreversible renal failure due to intratubular obstruction by triamterene crystal deposition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819215     DOI: 10.1159/000168364

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  3 in total

Review 1.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 2.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Raman Spectroscopy for the Diagnosis of Intratubular Triamterene Crystallization.

Authors:  C John Sperati; Chi Zhang; Marco Delsante; Rajib Gupta; Serena Bagnasco; Ishan Barman
Journal:  Kidney Int Rep       Date:  2018-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.